Peritoneal Dialysis Guidelines 2019 Part 1 (Position paper of Japanese Society of Dialysis Therapy)
Autor: | Noritomo Itami, Kei Nishiyama, Yuichi Ishikawa, Yoshihiko Kanno, Hiroshi Hataya, Masaaki Nakayama, Yasuhiko Ito, Hidetomo Nakamoto, Akihiro C. Yamashita, Atsushi Ueda, Hidemichi Yuasa, Hitoshi Sugiyama, Hideki Kawanishi, Motoshi Hattori, Kenichiro Miura, Riku Hamada, Tadashi Tomo, Hiroyuki Terawaki, Munekazu Ryuzaki, Hideki Yokoi, Yoshie Kanazawa, Kazuhiko Tsuruya, Hyogo Nakakura, Minoru Ito, Mizuya Fukasawa |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Encapsulating Peritoneal Sclerosis Dialysis Therapy Urology medicine.medical_treatment Optimal dialysis Peritoneal dialysis 030232 urology & nephrology 030204 cardiovascular system & hematology Peritonitis Nutritional management 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Peritoneal function Intensive care medicine Transplantation business.industry Icodextrin Solution Standard methods Diseases of the genitourinary system. Urology Clinical Practice Systematic review Nephrology Position paper RC870-923 EPS business |
Zdroj: | Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-77 (2021) |
ISSN: | 2059-1381 |
Popis: | Approximately 10 years have passed since the Peritoneal Dialysis Guidelines were formulated in 2009. Much evidence has been reported during the succeeding years, which were not taken into consideration in the previous guidelines, e.g., the next peritoneal dialysis PD trial of encapsulating peritoneal sclerosis (EPS) in Japan, the significance of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), the effects of icodextrin solution, new developments in peritoneal pathology, and a new international recommendation on a proposal for exit-site management. It is essential to incorporate these new developments into the new clinical practice guidelines. Meanwhile, the process of creating such guidelines has changed dramatically worldwide and differs from the process of creating what were “clinical practice guides.” For this revision, we not only conducted systematic reviews using global standard methods but also decided to adopt a two-part structure to create a reference tool, which could be used widely by the society’s members attending a variety of patients. Through a working group consensus, it was decided that Part 1 would present conventional descriptions and Part 2 would pose clinical questions (CQs) in a systematic review format. Thus, Part 1 vastly covers PD that would satisfy the requirements of the members of the Japanese Society for Dialysis Therapy (JSDT). This article is the duplicated publication from the Japanese version of the guidelines and has been reproduced with permission from the JSDT. |
Databáze: | OpenAIRE |
Externí odkaz: |